This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyfors, S.
Right arrow Articles by Jousimies-Somer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyfors, S.
Right arrow Articles by Jousimies-Somer, H.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 1999, p. 1591-1594, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

beta -Lactamase Production by Oral Anaerobic Gram-Negative Species in Infants in Relation to Previous Antimicrobial Therapy

S. Nyfors,1,2 E. Könönen,1,3,* A. Takala,4 and H. Jousimies-Somer1

Anaerobe Reference Laboratory1 and Department of Vaccines,4 National Public Health Institute, FIN-00300 Helsinki, and Institute of Dentistry, University of Helsinki, FIN-00014 Helsinki,2 Finland, and Department of Medical Microbiology and Immunology, University of Aarhus, DK-8000 Aarhus C, Denmark3

Received 2 September 1998/Returned for modification 16 December 1998/Accepted 17 April 1999


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The frequency of beta -lactamase production in gram-negative bacteria has increased considerably during recent years. In this study, beta -lactamase production by oral anaerobic gram-negative rods isolated from saliva was longitudinally examined for 44 Caucasian infants at the ages of 2, 6, and 12 months in relation to their documented exposure to antibiotics. Isolates showing decreased susceptibility to penicillin G (1 µg/ml) were examined for beta -lactamase production by using a chromogenic cephalosporin disk test. beta -Lactamase-positive, gram-negative anaerobic species were found in 11, 55, and 89% of each age group, respectively. beta -Lactamase production was most frequent among organisms of the Prevotella melaninogenica group. At 12 months, 73% of the infants harbored beta -lactamase-producing members of the P. melaninogenica group, 55% had nonpigmented Prevotella species, 25% had Porphyromonas catoniae, 23% had Fusobacterium nucleatum, and 5% had Capnocytophaga species. Several beta -lactamase-producing species could be simultaneously found in the infants' mouths. The presence of beta -lactamase-producing species was significantly associated with the infants' exposure to antibiotics through antimicrobial treatments given to the infants and/or their mothers.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

beta -Lactamases are enzymes that hydrolyze the beta -lactam ring of a beta -lactam drug, leading to the inactivation of the drug. This is the most common resistance mechanism, especially among the gram-negative bacteria (7). Until the latter half of the 1970s, penicillins and cephalosporins were in most cases still effective against oral gram-negative anaerobes. In 1977, Murray and Rosenblatt (16) reported a frequency of beta -lactamase production by Bacteroides melaninogenicus (now reclassified as Prevotella melaninogenica and several other pigmented gram-negative rods) exceeding 56%. During the 1980s and 1990s, the production of beta -lactamases by these bacteria steadily increased. Anaerobic gram-negative rods, including Prevotella, Porphyromonas, and Fusobacterium species, can be involved in pyogenic orofacial and upper respiratory tract infections. These organisms may also protect otherwise-susceptible pathogens from a beta -lactam agent, which in turn leads to a failure of penicillin treatment (6). Cases of clinical failure with penicillin treatment for human orofacial infections have been documented along with reports suggesting that previous penicillin therapy increases the incidence of penicillin-resistant bacteria in the oral cavity (2, 3, 8, 23).

Previous reports of beta -lactamase production have been based mainly on hospitalized adults and children. To our knowledge beta -lactamase production has not been studied for healthy infants in a nonhospital setting. Otitis media, among other upper respiratory tract infections, is one of the most common infections in childhood (22). This infection is often treated with antimicrobial agents, especially beta -lactam antibiotics. Therefore, if antibiotic use provokes beta -lactamase production (7), it would be reasonable to assume that young children easily harbor beta -lactamase-producing strains. Indeed, previous studies (12, 13) have shown that beta -lactamase production by certain groups of oral anaerobes in early childhood can be much more frequent than generally anticipated.

The aim of the present longitudinal study was to examine the age-related frequency of beta -lactamase-producing oral anaerobic gram-negative species in infants during their first year of life in relation to their exposure to antimicrobial agents.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Subjects. The original study population, from whom 50 consecutive healthy infants were chosen for a detailed bacteriologic investigation, comprised 329 children participating in the Finnish Otitis Media Cohort Study in Tampere, Finland, from 1994 to 1997. The infants attended scheduled visits at the study clinic, where bacterial samples were collected and a wide variety of background data was gathered by interviewing the parent(s). If an infant became sick between the visits, the infection was treated in the same clinic, which provided the information of the antimicrobial history. Forty-four Caucasian infants, 2, 6, and 12 months of age, with complete bacteriologic and demographic data were included in the present study.

Bacterial samples and culture. During the scheduled visits, unstimulated saliva samples (0.1 to 0.3 ml) were collected from the cheek area with a calibrated plastic pipette. The measured samples were placed in VMGA III transport medium (5), delivered to the laboratory by overnight mail, and processed within 24 h.

The samples were dispersed by a vortex mixer, serially diluted in prereduced peptone-yeast extract broth, and cultured on several nonselective and selective media, including brucella agar, kanamycin-vancomycin-laked blood agar, neomycin-vancomycin agar, and Trypticase soy-serum-bacitracin-vancomycin agar, for the isolation of anaerobic gram-negative rods, as previously described (10). The media were incubated under anaerobic conditions for 5 to 7 days for the first inspection and for up to 14 days for the final examination. All different colony types were isolated and identified by use of established laboratory methods (9, 20).

Testing of beta -lactamase activity. Out of 735 anaerobic gram-negative isolates, 195 isolates showing decreased susceptibility to penicillin G (1 µg/ml; inhibition zone <= 20 mm) (as determined with special potency antibiotic disks [Oxoid, Unipath Limited, Basingstoke, Hampshire, United Kingdom]) were included for further examination (12). beta -Lactamase production was tested by using the qualitative chromogenic cephalosporin disk test (nitrocefin; AB Biodisk, Solna, Sweden). The results were read after 15, 30, and 60 min.

Statistics. The statistical significance of the association between the amount of beta -lactamase-producing species or groups and the exposure to antimicrobial agents was tested by using Mantel-Haenzel chi-square statistics. The exposure to antimicrobial agents was counted as follows: mothers' antimicrobial courses (in 15 cases) during the 6-month period before the first sampling occasion, at 2 months of age (maternal exposure); infants' antimicrobial courses between 2 and 6 months of age (early exposure); and infants' antimicrobial courses between 6 and 12 months of age (late exposure).


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

During the infants' (n = 44) first year of life, the occurrence of beta -lactamase-producing gram-negative anaerobic species or groups increased with age, from 11% (5 infants) at 2 months to 55% (24 infants) at 6 months to 89% (39 infants) at 12 months. The mean number of beta -lactamase-producing species or groups per subject increased from 0.1 (range, 0 to 2) at 2 months to 1.8 (range, 0 to 4) at 12 months (Table 1). The age-related frequency and distribution of beta -lactamase-producing bacteria by species or groups are presented in Table 2. The most pronounced changes were observed in the colonization of the Prevotella melaninogenica group (Prevotella denticola, Prevotella loescheii, and P. melaninogenica), which increased from 11% at 2 months to 73% at 12 months. Other beta -lactamase-producing species with a frequency exceeding 20% at 12 months consisted of nonpigmented Prevotella species (including pentose fermenters and nonfermenters), Porphyromonas catoniae, and Fusobacterium nucleatum. The decreased susceptibility (inhibition zone <=  20 mm) to penicillin (1 µg/ml), as determined with a penicillin G-impregnated disk, coincided well with the beta -lactamase production by a qualitative chromogenic cephalosporin disk test, except for two isolates. Follow-up colonization by beta -lactamase-producing species was assessed by comparing the positive findings obtained at 6 months with those (positive or negative) obtained at 12 months. Fourteen of the 16 infants who at 6 months of age harbored beta -lactamase-producing P. melaninogenica group isolates still harbored them at 12 months of age. Two of three infants still harbored nonpigmented Prevotella group isolates at 12 months, and one of four infants still harbored beta -lactamase-producing P. catoniae isolates at 12 months.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Number of infants at various ages harboring beta -lactamase-producing gram-negative anaerobic species or groups


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Distribution and age-related frequency of beta -lactamase-producing bacterial isolates by species or groups

Thirteen infants had not been exposed to antimicrobial agents through maternal or personal courses during their first year of life. They harbored, on average, 1.31 beta -lactamase-producing species or groups each at 12 months. Seventeen children who had had one or two exposures to antimicrobial agents through maternal courses (antimicrobial preparation not known) or personal courses (including beta -lactams and/or trimethoprim-sulfamethoxazole combinations intermittently) harbored, on average, 1.82 beta -lactamase-producing species or groups each. Children with three or more exposures to antimicrobial courses (including maternal courses and beta -lactams and/or trimethoprim-sulfamethoxazole combinations intermittently) harbored, on average, 2.21 beta -lactamase-producing species or groups each at 12 months. Twenty-six of the 31 children exposed to antimicrobial agents were exposed to beta -lactams. The most common indication for medication was otitis media, and the most common antimicrobial agents used were amoxicillin (38 courses) and a trimethoprim-sulfamethoxazole combination (28 courses). The number of antimicrobial treatments given to the infants during their first year of life varied between 0 and 9 per infant. Six infants were on antimicrobials during one or more sampling occasions.

A correlation between maternal antimicrobial exposure and the number of beta -lactamase-producing species or groups observed in infants at the age of 12 months was detected (P = 0.026). No positive correlation between early exposure and beta -lactamase production at 12 months of age could be found. A clear correlation between late exposure and beta -lactamase-producing species or groups in infants at 12 months of age was detected (P = 0.006) (data not shown). The Mantel-Haenzel chi-square analyses showed a significant association between the exposure to antimicrobial agents during the first year of life and the amount of beta -lactamase-producing species at 12 months (Table 3).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   No. of antibiotic exposures during the first year of infants' lives and the number of beta -lactamase-producing species at 12 months


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The frequency of beta -lactamase production by anaerobic gram-negative rods increased considerably during the first year of life of the study infants. In addition, the number of simultaneously isolated beta -lactamase-producing species also increased with age. Previous antimicrobial exposures had a significant effect on the development of resistance.

The predisposing factors involved in the origin and evolution of beta -lactamase production remain unclear. Almost all gram-negative rods produce small amounts of chromosomal beta -lactamases (21). However, beta -lactamases encoded by genes that are transferred extrachromosomally, as well as strong induction of chromosomal beta -lactamases, have caused great clinical problems during recent years. As reported earlier, the use of antimicrobial drugs has been known to increase the frequency of beta -lactamase production for both anaerobes and aerobes (17, 19). Acute otitis media episodes are especially common during the first year of life (1, 22), and they are the main reason for antimicrobial treatment, often recurrent, in early infancy. It is generally accepted that to limit the spread of bacterial resistance, the use of antimicrobial agents should be controlled. To combat bacterial infections, it is necessary that the dosage to be administered is proper, as subinhibitory concentrations may lead to gradual development of plasmid-mediated resistance under selection pressure or acquisition of resistance genes from other bacteria (17). In the present study, the infants who had no personal antibiotic history during the surveillance year or maternal exposure before the age of 2 months harbored, on average, 1.31 beta -lactamase-producing species at 12 months of age. When the infants had been exposed to antimicrobial agents (in most cases alone but in some cases in combination with another antimicrobial agent[s]), the number of beta -lactamase-producing species increased significantly. Our observation is well in line with that of Brook and Gober (4), who demonstrated an increase in the number of penicillin-resistant oropharyngeal bacteria due to the use of amoxicillin as preventive medication against recurrent otitis media in children. In addition to an infant's exposure to antibiotics, we also estimated the possible influence of the mother's antimicrobial use on the colonization of beta -lactamase-producing bacteria in infants. Indeed, bacterial transmission from mothers to infants could explain why infants at 2 months of age whose mothers were on antimicrobial medication harbored more beta -lactamase-producing species than infants with no exposure at all. Selection of beta -lactamase-producing subpopulations and proliferation of them could explain the high incidence of resistant species at 12 months.

Plasmid-mediated resistance in the bacteria of both humans and animals has been previously described (24). However, plasmid analysis performed for P. melaninogenica in a previous study (12) showed no correlation between the production of beta -lactamase and the presence of plasmids. It has been suggested that genes that encode resistance to tetracyclines and penicillin from anaerobes from different families and species may be transferred together to the host (18, 24). However, according to a recent study (14), beta -lactamase-producing F. nucleatum isolates from young children were resistant to penicillin G (MICs, 2 to 256 µg/ml) but susceptible to tetracycline hydrochloride. The factors behind beta -lactamase production need to be investigated further. Aspects of special interest would be the composition of the oral microflora and the antimicrobial drug history of the family members. Special attention should be paid to children in day care, as they are more likely to be exposed to and transmit early acute otitis media to their infant siblings (15).

According to a previous study (11), strain turnover may easily occur in young children with a developing oral ecosystem. In this study, some of the infants who harbored beta -lactamase-producing isolates at 6 months did not harbor them at 12 months. It is possible that a turnover of the bacterial population in the biological environment, from beta -lactamase-positive strains to beta -lactamase-negative strains, had occurred or that methodologic biases included adverse factors inherent in the sampling efficacy or merely in the ability to isolate the index species from mixed cultures. However, to evaluate the stability of a strain, genetic methods (e.g., ribotyping, arbitrarily primed PCR, or an equivalent method) should be used to document the degree of clonal similarity.

One of the explanations for the high frequency of beta -lactamase production is certainly the fact that P. melaninogenica is a genotypically heterogeneous species (11), which means that one individual can simultaneously harbor several strains with different characteristics, in this case both beta -lactamase-positive and beta -lactamase-negative strains, and with indistinguishable genotypes (12). Therefore, in this study several isolates per infant, if available, were tested for beta -lactamase production, because if only one isolate per infant had been tested, the true rate of colonization by beta -lactamase-producing strains might have been underestimated.

The child's immediate environment and close contacts have a great influence on the development of the early oral microflora. On the basis of the present investigation, we conclude that the high frequency of beta -lactamase-producing bacterial strains reflects the net effect of the child's and the family members', especially the mother's, antibiotic exposure.


    ACKNOWLEDGMENTS

We thank Ritva Syrjänen, Marja-Leena Hotti, Mervi Martola, and Päivi Tervonen for clinical monitoring; Arja Kanervo and Eveliina Tarkka for assistance with identification of bacterial isolates; Merja Rautio for technical assistance; and Eeva Koskenniemi and Jorma Torppa for statistical analysis.


    FOOTNOTES

* Corresponding author. Mailing address: National Public Health Institute, Anaerobe Reference Laboratory, Mannerheimintie 166, FIN-00300 Helsinki, Finland. Phone: 358-9-47448248. Fax: 358-9-47448238. E-mail: Eija.Kononen{at}ktl.fi.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Alho, O. P., M. Koivu, M. Sorri, and P. Rantakallio. 1991. The occurrence of acute otitis media in infants: a life-table analysis. Int. J. Pediatr. Otorhinolaryngol. 21:7-14[Medline].
2. Brook, I., L. Calhoun, and P. Yocum. 1980. Beta-lactamase-producing isolates of Bacteroides species from children. Antimicrob. Agents Chemother. 18:164-166[Abstract/Free Full Text].
3. Brook, I., and A. E. Gober. 1995. Role of bacterial interference and beta -lactamase-producing bacteria in the failure of penicillin to eradicate group A-streptococcal pharyngotonsillitis. Arch. Otolaryngol. Head Neck Surg. 121:1405-1409.
4. Brook, I., and A. E. Gober. 1996. Prophylaxis with amoxicillin or sulfisoxazole for otitis media: effect on the recovery of penicillin-resistant bacteria from children. Clin. Infect. Dis. 22:143-145[Medline].
5. Dahlén, G., P. Pipattanagovit, B. Rosling, and Å. J. R. Möller. 1993. A comparison of two transport media for saliva and subgingival samples. Oral Microbiol. Immunol. 8:375-382[Medline].
6. Hackman, A. S., and T. D. Wilkins. 1976. Influence of penicillinase production by strains of Bacteroides melaninogenicus and Bacteroides oralis in penicillin therapy of an experimental mixed anaerobic infection in mice. Arch. Oral Biol. 21:385-389[Medline].
7. Hedberg, M., and C. E. Nord. 1996. Antimicrobial-resistant anaerobic bacteria in human infections. Med. Microbiol. Lett. 5:295-304.
8. Heimdahl, A., L. von Konow, and C. E. Nord. 1981. Beta-lactamase-producing Bacteroides species in the oral cavity in relation to penicillin therapy. J. Antimicrob. Chemother. 8:225-229[Abstract/Free Full Text].
9. Jousimies-Somer, H. R., P. H. Summanen, and S. M. Finegold. 1995. Bacteroides, Porphyromonas, Prevotella, Fusobacterium, and other anaerobic gram-negative bacteria, p. 603-620. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. L. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
10. Könönen, E., A. Kanervo, A. Takala, S. Asikainen, and H. R. Jousimies-Somer. Establishment of oral anaerobes during the first year of life. J. Dent. Res., in press.
11. Könönen, E., M. Saarela, J. Karjalainen, H. Jousimies-Somer, S. Alaluusua, and S. Asikainen. 1994. Transmission of oral Prevotella melaninogenica between a mother and her young child. Oral Microbiol. Immunol. 9:304-310.
12. Könönen, E., M. Saarela, A. Kanervo, J. Karjalainen, S. Asikainen, and H. Jousimies-Somer. 1995. beta -Lactamase production and penicillin susceptibility among different ribotypes of Prevotella melaninogenica simultaneously colonizing the oral cavity. Clin. Infect. Dis. 20(Suppl. 2):S364-S366.
13. Könönen, E., S. Nyfors, J. Mättö, S. Asikainen, and H. Jousimies-Somer. 1997. beta -Lactamase production among oral pigmented Prevotella species in young children. Clin. Infect. Dis. 25(Suppl. 2):S272-S274.
14. Könönen, E., A. Kanervo, K. Salminen, and H. Jousimies-Somer. 1999. beta -Lactamase production and antimicrobial susceptibility of oral heterogeneous Fusobacterium nucleatum populations in young children. Antimicrob. Agents Chemother. 43:1270-1273[Abstract/Free Full Text].
15. Kvaerner, K. J., P. Nafstad, J. Hagen, I. W. S. Mair, and J. J. K. Jaakkola. 1997. Early acute otitis media: determined by exposure to respiratory pathogens. Acta Oto-laryngol. 529(Suppl.):14-18.
16. Murray, P. R., and J. E. Rosenblatt. 1977. Penicillin resistance and penicillinase production in clinical isolates of Bacteroides melaninogenicus. Antimicrob. Agents Chemother. 11:605-608[Abstract/Free Full Text].
17. Nord, C. E., L. Kager, and A. Heimdahl. 1984. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. Am. J. Med. 15:99-106.
18. Rasmussen, B. A., K. Bush, and F. P. Tally. 1997. Antimicrobial resistance in anaerobes. Clin. Infect. Dis. 24(Suppl. 1):S110-S120.
19. Stark, C., C. Edlund, M. Hedberg, and C. E. Nord. 1995. Induction of beta-lactamase by cefoxitin in anaerobic intestinal microflora. Eur. J. Clin. Microbiol. Infect. Dis. 14:18-24[Medline].
20. Summanen, P., E. J. Baron, D. M. Citron, C. Strong, H. M. Wexler, and S. M. Finegold. 1993. Wadsworth anaerobic bacteriology manual, 5th ed. Star Publishing Co., Belmont, Calif.
21. Sykes, R. B., and M. Matthew. 1976. The beta -lactamases of gram-negative bacteria and their role in resistance to beta -lactam antibiotics. J. Antimicrob. Chemother. 2:115-157[Free Full Text].
22. Teele, D. W., J. O. Klein, B. Rosner, and the Greater Boston Otitis Media Study Group. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160:83-94[Medline].
23. Tunér, K., and C. E. Nord. 1983. Beta-lactamase-producing microorganisms in recurrent tonsillitis. Scand. J. Infect. Dis. 39(Suppl.):83-85.
24. Walker, C. B. 1996. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol. 2000 10:79-88[Medline].


Antimicrobial Agents and Chemotherapy, July 1999, p. 1591-1594, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Voha, C., Docquier, J.-D., Rossolini, G. M., Fosse, T. (2006). Genetic and Biochemical Characterization of FUS-1 (OXA-85), a Narrow-Spectrum Class D {beta}-Lactamase from Fusobacterium nucleatum subsp. polymorphum.. Antimicrob. Agents Chemother. 50: 2673-2679 [Abstract] [Full Text]  
  • Nyfors, S., Kononen, E., Syrjanen, R., Komulainen, E., Jousimies-Somer, H. (2003). Emergence of penicillin resistance among Fusobacterium nucleatum populations of commensal oral flora during early childhood. J Antimicrob Chemother 51: 107-112 [Abstract] [Full Text]  
  • Galán, J. C., Reig, M., Navas, A., Baquero, F., Blázquez, J. (2000). ACI-1 from Acidaminococcus fermentans: Characterization of the First beta -Lactamase in Anaerobic Cocci. Antimicrob. Agents Chemother. 44: 3144-3149 [Abstract] [Full Text]  
  • Jolivet-Gougeon, A., Buffet, A., Dupuy, C., Sixou, J.-L., Bonnaure-Mallet, M., David, S., Cormier, M. (2000). In Vitro Susceptibilities of Capnocytophaga Isolates to beta -Lactam Antibiotics and beta -Lactamase Inhibitors. Antimicrob. Agents Chemother. 44: 3186-3188 [Abstract] [Full Text]  
  • Summanen, P. H. (2000). Comparison of Effects of Medium Composition and Atmospheric Conditions on Detection of Bilophila wadsworthia beta -Lactamase by Cefinase and Cefinase Plus Methods. J. Clin. Microbiol. 38: 733-736 [Abstract] [Full Text]  
  • Kononen, E., Kanervo, A., Takala, A., Asikainen, S., Jousimies-Somer, H. (1999). Establishment of Oral Anaerobes during the First Year of Life. JDR 78: 1634-1639 [Abstract]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nyfors, S.
Right arrow Articles by Jousimies-Somer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nyfors, S.
Right arrow Articles by Jousimies-Somer, H.